{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:59:39Z","timestamp":1785333579771,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s13555-023-01013-y","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T15:03:06Z","timestamp":1694098986000},"page":"2473-2478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rapid Remission of Sunburn-Induced Guttate Psoriasis with Guselkumab"],"prefix":"10.1007","volume":"13","author":[{"given":"Erin","family":"Bartholomew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Young","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Yeroushalmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Hakimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Bhutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7883-6439","authenticated-orcid":false,"given":"Wilson","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"issue":"4","key":"1013_CR1","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaci.2014.01.025","volume":"133","author":"H Sofen","year":"2014","unstructured":"Sofen H, Smith S, Matheson RT, et\u00a0al. Guselkumab (an IL-23\u2013specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis. J Allergy Clin Immunol. 2014;133(4):1032\u201340.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1013_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamadermatol.2017.5937","volume":"154","author":"T Terui","year":"2018","unstructured":"Terui T, Kobayashi S, Okubo Y, Murakami M, Hirose K, Kubo H. Efficacy and safety of guselkumab, an anti\u2013interleukin 23 monoclonal antibody, for palmoplantar pustulosis: a randomized clinical trial. JAMA Dermatol. 2018;154(3):309.","journal-title":"JAMA Dermatol"},{"key":"1013_CR3","unstructured":"Saleh D, Tanner L. Saleh D, Tanner LS. Guttate Psoriasis. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2022."},{"issue":"5","key":"1013_CR4","doi-asserted-by":"publisher","first-page":"E70","DOI":"10.1111\/j.1525-1470.2007.00445.x","volume":"24","author":"KL Horner","year":"2007","unstructured":"Horner KL, Chien AJ, Edenholm M, Hornung RL. Winnie the pooh and psoriasis too: an isomorphic response of guttate psoriasis in a tattoo. Pediatr Dermatol. 2007;24(5):E70\u20132.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"1013_CR5","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1013_CR6","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1038\/jid.2014.261","volume":"134","author":"MBM Teunissen","year":"2014","unstructured":"Teunissen MBM, Yeremenko NG, Baeten DLP, et\u00a0al. The IL-17A-producing CD8 + T-Cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J Invest Dermatol. 2014;134(12):2898\u2013907.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1013_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaci.2016.02.008","volume":"138","author":"E Ruiz-Romeu","year":"2016","unstructured":"Ruiz-Romeu E, Ferran M, Sagrist\u00e0 M, et\u00a0al. Streptococcus pyogenes-induced cutaneous lymphocyte antigen-positive T cell-dependent epidermal cell activation triggers TH17 responses in patients with guttate psoriasis. J Allergy Clin Immunol. 2016;138(2):491-499.e6.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1013_CR8","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/1523-1747.ep12606202","volume":"104","author":"A Schwarz","year":"1995","unstructured":"Schwarz A, Bhardwaj R, Aragane Y, et\u00a0al. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-\u03b1 in the formation of sunburn cells. J Invest Dermatol. 1995;104(6):922\u20137.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"1013_CR9","first-page":"822","volume":"18","author":"S Hall","year":"2019","unstructured":"Hall S, Haidari W, Feldman SR. Resolution of guttate psoriasis plaques after one-time administration of guselkumab. J Drugs Dermatol. 2019;18(8):822\u20133.","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"1013_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/09546634.2013.782095","volume":"25","author":"A Amarnani","year":"2014","unstructured":"Amarnani A, Rosenthal KS, Mercado JM, Brodell RT. Concurrent treatment of chronic psoriasis and asthma with ustekinumab. J Dermatol Treat. 2014;25(1):63\u20136.","journal-title":"J Dermatol Treat"},{"issue":"5","key":"1013_CR11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jdcr.2017.06.015","volume":"3","author":"GC Brummer","year":"2017","unstructured":"Brummer GC, Hawkes JE, Duffin KC. Ustekinumab-induced remission of recalcitrant guttate psoriasis: a case series. JAAD Case Reports. 2017;3(5):432\u20135.","journal-title":"JAAD Case Reports"},{"key":"1013_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jdcr.2022.04.019","volume":"24","author":"A Flora","year":"2022","unstructured":"Flora A, Frew JW. A case series of early biologic therapy in guttate psoriasis: targeting resident memory T cell activity as a potential novel therapeutic modality. JAAD Case Reports. 2022;24:82\u20137.","journal-title":"JAAD Case Reports"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-01013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-01013-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-01013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T15:07:58Z","timestamp":1695913678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-01013-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-01013-y","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained under UCSF IRB approval protocol: 20-32273.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Dr. Wilson Liao, MD has received research funding from Abbvie, Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. Tina Bhutani is a principal investigator for trials sponsored by Abbvie, Castle, CorEvitas, Dermavant, Galderma, Mindera, and Pfizer. She has received research grant funding from Novartis and Regeneron. She has been an advisor for Abbvie, Arcutis, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Leo, Lilly, Novartis, Pfizer, Sun, and UCB. The remaining authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}